SEC filings and other documents

All proposals passed, with growth, innovation, and risk management highlighted.

Strong Q1 performance with rising margins, robust orders, and continued transformation initiatives.

Growth, margin expansion, and innovation are accelerating amid strong industrial performance.

Strong growth, margin expansion, and innovation drive positive 2026 outlook and capital returns.

Transformation drives growth, innovation, and margin gains amid mixed market trends.

Strong Q3 results, higher guidance, and robust cash flow despite special item impacts.

Accelerating growth and margins through innovation, operational excellence, and portfolio focus.

Q2 saw double-digit EPS growth, margin expansion, and raised full-year guidance amid macro headwinds.

PFAS settlement, margin gains, and innovation drive growth amid macro softness and culture change.

Board, auditor, and compensation proposals passed; innovation and risk management prioritized.

Q1 EPS up 10% year-over-year; 2025 EPS guidance held at $7.60–$7.90 despite tariff risks.

Operational focus, innovation, and cost control drive growth outlook amid macro and legal risks.

Targeting 1,000 new products, $1B productivity, and 25% margin by 2027 with disciplined execution.

Strong 2024 results and restructuring set the stage for growth and margin gains in 2025.